mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.01 |
mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.01 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
0.01 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.01 |